Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Ridgeline Minerals sells Nevada gold exploration portfolio to Nevada Gold Mines for US$23.15 million

Ridgeline Minerals sells Nevada gold exploration portfolio to Nevada Gold Mines for US$23.15 million

ReutersReuters2026/08/04 11:34
  • Ridgeline Minerals agreed to sell its Swift, Black Ridge, Bell Creek, Atlas Nevada gold exploration assets to Nevada Gold Mines for USD 23.15 million cash.
  • Deal closed effective Aug. 3, 2026. Nevada Gold Mines takes 100% ownership of the portfolio.
  • Ridgeline expects to retain about CAD 33 million cash. It also holds CAD 3 million in Spartan Metals shares.
  • Company keeps its Selena earn-in with South32. It also retains the Big Blue copper-CRD project and the Coyote gold project.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ridgeline Minerals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608040730NEWSFILECNPR____20260804_307876_1) on August 04, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage